Next Generation Sequencing Market Outlook 2027 By Top Manufacturers Agilent, BGI, Illumina, Qiagen, Roche and Thermo Fisher Scientific

The next generation sequencing market is estimated to procure steady growth driven by robust application of NGS tools in the medical research field and clinical diagnosis. Growing usage of NGS techniques by biopharmaceutical and pharmaceutical firms along with prevalence of chronic illnesses like diabetes and cancer is giving a boost to technology demand. These firms are investing in R&D activities to create alternative solutions and make personalized medicines for different diseases.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/3247

Next generation sequencing methods are used for studying genomes and identifying problems caused in genes due to disease development. Businesses have created NGS library preparation kits automated data analysis tools, and sequencing instruments for the studying of genes. Companies operating in the NGS market are working on new technologies and products. For example, in 2019, Agilent Technologies announced a next generation sequencing library preparation system made to run complex DNA sequencing assays easily with a button press. Based on such innovations, Global Market Insights, Inc., reports that the next generation sequencing market is projected to surpass USD 22 billion by 2027.

In terms of product type, the next generation sequence services segment is likely to register a CAGR of around 20% over the forecast period. These services are extensively available in areas such as RNA sequencing, cancer analysis services, metagenomics solutions, whole genome sequencing, and oligo synthesis.

Based on type, the target sequencing section is anticipated to register around USD 700 million in 2020 owing to rising demand for personalized medicines. The targeted sequencing type correctly measures individual’s gene pool which can be used for personalized medicines. With the variation of genetic makeup from individual to individual, the concentration of drugs meant for consumption also varies.

With respect to technology, sequencing by synthesis segment is likely to witness approximately 20.6% CAGR in the upcoming years. Sequencing by synthesis enables accurate and quick DNA analysis, and is a cost-effective option. The whole human genome can be sequenced in a few hours given to the availability of technologically advanced equipment.

Request for customization @ https://www.gminsights.com/roc/3247

In terms of end-use, the demand from academic institutes and research centers accounted for above USD 2.5 billion in 2020. This can be credited to growing research efforts on genomic aspects with the use of NGS methods. Research institutes receive funds from governments to promote advancements in drug discovery processes. In this way, academic institutes and research laboratories are well-equipped with modern NGS devices.

Globally, companies in the next generation sequencing market are Roche, Qiagen, Agilent, Bio-Rad Laboratories, BGI, Thermo Fisher Scientific, Illumina, and Genapsys. These organizations are focusing on new product launches, partnerships, and mergers to boost their market position.

Partial Chapter of the Table of Content

Chapter 4 Next Generation Sequencing Market, By Product Type

4.1 Key segment trends

4.2 Instruments

4.2.1 Market size, by region, 2016 – 2027

4.3 Consumables

4.3.1 Market size, by region, 2016 – 2027

4.4 Services

4.4.1 Market size, by region, 2016 – 2027

Chapter 5 Next Generation Sequencing Market, By Application

5.1 Key segment trends

5.2 Research

5.2.1 Market size, by region, 2016 – 2027

5.3 Clinical

5.3.1 Market size, by region, 2016 – 2027

5.3.2 Cardiovascular

5.3.2.1 Market size, by region, 2016 – 2027

5.3.3 Reproductive health

5.3.3.1 Market size, by region, 2016 – 2027

5.3.4 Cancer

5.3.4.1 Market size, by region, 2016 – 2027

5.3.5 Infectious diseases

5.3.5.1 Market size, by region, 2016 – 2027

5.3.6 Others

5.3.6.1 Market size, by region, 2016 – 2027

5.4 Others

5.4.1 Market size, by region, 2016 – 2027

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/next-generation-sequencing-market

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

This release was published on openPR.